News
S&P 500—currently near its all-time highs, with a recent closing benchmark at approximately 6,450—stands at a crossroads.
Gift Nifty was trading around 24,894 level, a premium of nearly 210 points from the Nifty futures’ previous close, indicating a gap-up start for the Indian stock market indices.
Dow, S&P 500, and Nasdaq futures are falling in premarket trading as the stock market braces for President Donald Trump's Ukraine meeting. The Federal Reserve's Jackson Hole Symposium and Retail ...
U.S. stock market futures leaned lower on Monday, as investors awaited the result from the visit of European leaders to the ...
6hon MSN
Stock market today: Gift Nifty up 270 pts; key levels to watch for Nifty, Sensex, Nifty Bank
Nifty futures on the NSE International Exchange traded 267.80 points, or 1.08 per cent, down at 24,952.50, hinting at a muted ...
20m
InvestorsHub on MSNDow Jones, S&P, Nasdaq, Wall Street Futures, Trump-Zelensky Meeting Looms, Fed Rate Outlook Captures Investor Attention
U.S. stock futures showed little movement ahead of a critical Washington meeting between President Donald Trump and Ukrainian ...
Japan's Nikkei share average extended its gains from last week to end at a record high on Monday, as a weaker yen pushed ...
Dow Jones Industrial Average futures (YM00) were up fractionally, about 30 points, while S&P 500 futures (ES00) and Nasdaq-100 futures (NQ00) also inched higher. Bitcoin prices (BTCUSD) rose, just ...
SCHB closely mirrors the S&P 500, offering low-cost exposure with limited alpha due to large-cap dominance and rare small/mid ...
In Asia, markets opened on a mixed note amid geopolitical tensions. Japan's Nikkei 225 was up 0.4%, while South Korea's KOSPI ...
6h
Investor's Business Daily on MSNDow Jones Futures: Fed Chief Powell May Back Rate Shift; Tesla, Micron, AppLovin Eye New Buy Points
The stock market is at highs, with Fed chief Powell set to give a big speech. Tesla, Micron and AppLovin are forging new buy points.
Novo Nordisk shares (DK:NOVO.B) (NVO) rose 4% in Copenhagen trade. The stock however has plunged 46% this year amid increased competition for its weight-loss drugs as well as turmoil at the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results